Tag: glioblastoma research
-
Major UK trial to assess whether cannabis-based drug could extend life for thousands with aggressive brain tumours
A major UK trial of cannabis-based drug Sativex in treating the most aggressive form of brain tumour is to launch at 15 NHS hospitals, following promising results from a phase I study in 27 patients.
-
Telomeres- a cancer cell’s fountain of youth
If we can find a way to interrupt a cancer cell’s ability to keep dividing, we may have a key to stopping tumours growing. Researchers, Dr Wong and Dr Voon ,tells us about the discovery they made into a tumour’s ability to continuously divide.
-
Stem cells are teaching us about glioblastoma
New research shows that stem cells may be primed to activate. This early stage research could lead us to the reason glioblastomas recur so quickly.
-
Shining a light on the differences between glioblastoma cells
A new publication from one of our research projects shines a light on the differences between the cells in the middle/core of a glioblastoma (GBM) compared to the cells spreading/infiltrating into healthy brain around the tumour.
-
Immunotherapy before surgery for recurring glioblastoma
Research suggests that treating people who have recurrent glioblastoma with immunotherapy before surgery, as well as afterwards, could be more effective
-
New ‘gel’ device lures aggressive brain tumour cells out
A new device nicknamed the “Tumor Monorail” has just received breakthrough device designation by the U.S. Food and Drug Administration (FDA)
-
Does your sex matter when you have a glioblastoma?
Recent research has shown that sex differences impact outcomes for people diagnosed with a glioblastoma. These differences go beyond hormone influences and were found to be intrinsic to tumour cells
-
A potential combination treatment targeting glioblastoma
A team of researchers at UCLA have discovered a combination of drugs to prevent the growth of glioblastomas, as well as kill tumour cells in mice with glioblastomas
-
Awarding the WINDOW Consortium £1.5 million for new research into glioblastoma
We have awarded the Dutch/British WINDOW Consortium a grant of £1.5 million (€1.75 million) for research into Glioblastoma
-
The latest research developments using the Zika virus to treat glioblastoma
A team of researchers investigated the effect of the Zika virus on glioblastoma cells in mice, as well as in human brain tissue samples. They discovered that the virus infected and killed the cancerous cells
-
The United States Food and Drug Association has approved the investigation of a new immunotherapy drug targeting Glioblastoma
This means that 1/2a clinical trials using the drug VBI-1901 can now begin later this year in patients with recurrent GBM. The trials will examine the safety and effectiveness of the drug
-
Scientists have discovered a protein that could potentially predict glioblastoma outcomes
Scientists from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the protein BCL6 could potentially be used as a marker to predict the clinical outcome of patients with glioblastoma
-
Could the Zika virus be used to treat glioblastomas?
The University of Cambridge is to begins trials using the Zika virus on glioblastoma, the most common and aggressive form of brain tumour. Glioblastomas affect 2,200 people in the UK each year
-
Edinburgh research discovers new relationship between immune and glioblastoma cells
Research carried out at the University of Edinburgh has revealed a new alliance between immune cells and glioblastoma tumour cells in zebrafish.
-
New device ‘extends survival’ for glioblastoma patients, trial finds
A battery-powered cap that disrupts the growth of brain tumour cells could help glioblastoma patients to survive for longer, new findings suggest.
-
US doctors test new glioblastoma drug treatment
US doctors are testing a new glioblastoma drug treatment with early results looking positive.
-
Genetically-modified polio virus used in trials treating glioblastoma
A team from Duke’s University, North Carolina, have pioneered using a genetically-engineered polio virus as a method for tackling brain tumours.
-
China joins glioblastoma Australian clinical trial project
China joins GBM AGILE, an Australasian adaptive clinical trial project tackling glioblastoma multiforme.
-
American research identifies glioblastoma-limiting drug
Scientists from the Translational Genomics Research Institute have identified the drug propentofylline (PPF) that limits the protein TROY in glioblastoma (GBM) cells and that also increases the effectiveness of chemotherapy drug temozolomide and radiation to treat GBM.
-
American federal agency approves new medical device for use in treatment of glioblastoma
The American Food and Drug Administration (FDA) has just approved Optune for the treatment of gioblastoma multiforme (GBM) patients.